Boston Private Bank & Trust’s Albany Molecular Research Inc AMRI Stock Holding History

Boston Private Bank & Trust’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$33K	Hold	1,855	–	–	﹤0.01%	645
2014 Q4	$30K	Hold	1,855	–	–	﹤0.01%	675
2014 Q3	$41K	Hold	1,855	–	–	﹤0.01%	627
2014 Q2	$37K	Hold	1,855	–	–	﹤0.01%	624
2014 Q1	$34K	Hold	1,855	–	–	﹤0.01%	664
2013 Q4	$19K	Buy	+1,855	New	+$22.4K	﹤0.01%	756

Other funds holding AMRI

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Boston Private Bank & Trust's AMRI Position: Q1 2015 in Review

Boston Private Bank & Trust held its Albany Molecular Research Inc (AMRI) position steady in Q1 2015 at 1,855 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #645.

Boston Private Bank & Trust first reported a position in AMRI in Q4 2013 and has held it in 6 quarters since. The position peaked at $41K in Q3 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

Boston Private Bank & Trust held 1,855 shares of Albany Molecular Research Inc worth $33K as of Q1 2015.
Boston Private Bank & Trust left its Albany Molecular Research Inc share count unchanged in Q1 2015.
Albany Molecular Research Inc made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #645 holding.
Boston Private Bank & Trust first reported a position in Albany Molecular Research Inc in Q4 2013 and has held it in 6 quarters since.
Boston Private Bank & Trust's Albany Molecular Research Inc position peaked at $41K in Q3 2014.
131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.